The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study-Reference-Cited by-同舟云学术

The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study

Published:2020-05 Issue: Volume:130 Page:39-50
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Michot Jean-Marie,Lappara Ariane,Le Pavec Jérôme^ORCID,Simonaggio Audrey^ORCID,Collins Michael,De Martin Eléonora,Danlos François-Xavier,Ammari Samy,Cauquil Cécile,Ederhy Stéphane,Barreau Emmanuel,Belkhir Rakiba,Berdelou Amandine,Lazarovici Julien,Chanson Philippe,Izzedine Hassan,Seferian Andrei,Le Pajolec Christine,Baldini Capucine,Martin-Romano Patricia,Mariette Xavier,Robert Caroline,Besse Benjamin,Hollebecque Antoine,Varga Andrea,Laghouati Salim,Mateus Christine,Voisin Anne-Laure,Soria Jean-Charles,Massard Christophe,Marabelle Aurélien,Champiat Stéphane,Lambotte Olivier

Funder

Gustave Roussy

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade;Hirsch;Br J Canc,2019

3. Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma;Weber;J Clin Oncol,2017

4. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial;Fehrenbacher;Lancet,2016

5. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Haanen;Ann Oncol Off J Eur Soc Med Oncol,2017

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Practices in Immune-Related Adverse Event Management: Insights From the IMMUCARE Multidisciplinary Board;JCO Oncology Practice;2024-07-22

2. Real-World Prevalence and Tolerability of Immune-Related Adverse Events in Older Adults with Non-Small Cell Lung Cancer: A Multi-Institutional Retrospective Study;Cancers;2024-06-06

3. Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations;Cancer Treatment Reviews;2024-06

4. Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome;American Journal of Hematology;2024-04-20

5. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04